EDMONTON, ALBERTA--(MARKET WIRE)--Jul 25, 2007 -- New Management of ViRexx Medical Corp. (“ViRexx”) (Toronto:VIR.TO - News) (AMEX:REX - News), has reduced monthly development expenses from $1.1 million to $642,000 since they were appointed on May 3 this year, allowing it to continue to develop platforms for another nine months, with current cash on hand.
